DK428089A - Anvendelse af plasminogen-aktivator-inhibitor (pai-2) til immunsuppression - Google Patents

Anvendelse af plasminogen-aktivator-inhibitor (pai-2) til immunsuppression

Info

Publication number
DK428089A
DK428089A DK428089A DK428089A DK428089A DK 428089 A DK428089 A DK 428089A DK 428089 A DK428089 A DK 428089A DK 428089 A DK428089 A DK 428089A DK 428089 A DK428089 A DK 428089A
Authority
DK
Denmark
Prior art keywords
pai
plasminogen activator
activator inhibitor
immune expression
immune
Prior art date
Application number
DK428089A
Other languages
Danish (da)
English (en)
Other versions
DK428089D0 (da
Inventor
Thomas Stief
Norbert Heimburger
Hans Ulrich Schorlemmer
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK428089D0 publication Critical patent/DK428089D0/da
Publication of DK428089A publication Critical patent/DK428089A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK428089A 1988-08-31 1989-08-30 Anvendelse af plasminogen-aktivator-inhibitor (pai-2) til immunsuppression DK428089A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3829523A DE3829523A1 (de) 1988-08-31 1988-08-31 Verwendung von plasminogen-aktivator-inhibitor (pai-2) zur immunsuppression

Publications (2)

Publication Number Publication Date
DK428089D0 DK428089D0 (da) 1989-08-30
DK428089A true DK428089A (da) 1990-03-01

Family

ID=6361973

Family Applications (1)

Application Number Title Priority Date Filing Date
DK428089A DK428089A (da) 1988-08-31 1989-08-30 Anvendelse af plasminogen-aktivator-inhibitor (pai-2) til immunsuppression

Country Status (9)

Country Link
EP (1) EP0356945B1 (pt)
JP (1) JPH02108633A (pt)
KR (1) KR900002791A (pt)
AT (1) ATE97576T1 (pt)
AU (1) AU616555B2 (pt)
DE (2) DE3829523A1 (pt)
DK (1) DK428089A (pt)
ES (1) ES2061842T3 (pt)
PT (1) PT91584B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4214215A1 (de) * 1992-04-30 1993-11-04 Behringwerke Ag Verwendung von inhibitoren von plasminogenaktivatoren zur behandlung von entzuendungen
CA2326438A1 (en) * 1998-04-01 1999-10-07 Biotech Australia Pty. Limited Use of protease inhibitors for treating skin wounds
AUPP508798A0 (en) * 1998-08-05 1998-08-27 Biotech Australia Pty Limited Method of treating psoriasis
EP1066834A3 (de) * 1999-07-08 2004-06-02 Thomas Dr. Stief Pharmazeutische Zusammensetzungen enthaltend ein phagozytenmodulierendes Agens
AU1123001A (en) 1999-10-27 2001-05-08 Alexandra Lucas Compositions and methods for preventing and treating transplant rejection
AUPQ380699A0 (en) * 1999-11-02 1999-11-25 Biotech Australia Pty Limited Protease inhibitors as modulators of periodontal wound healing
EP1365798B1 (en) 2000-09-29 2009-12-30 Viron Therapeutics, Inc. Use of serp-1 in combination with an immunosuppressant for treating arthritis
KR100550385B1 (ko) * 2002-11-11 2006-02-08 메타볼랩(주) 트랜스글루타미나아제를 포함하는 칸디다 속의 미생물과그의 숙주 세포 사이의 결합 저해제
JP4578067B2 (ja) * 2003-06-06 2010-11-10 宏 清水 局所医薬組成物
US7285530B2 (en) 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923807A (en) * 1984-05-18 1990-05-08 New England Medical Center Hospitals Inc. Arg-Serpin human plasminogen activator inhibitor designated PAI-2
WO1986003973A1 (en) * 1985-01-14 1986-07-17 Terumo Kabushiki Kaisha Fibrinophilic urokinase complex and process for its preparation
DE3713272A1 (de) * 1987-04-18 1988-11-03 Behringwerke Ag Plasminogenaktivator-inhibitor, typ 2 (pai-2)
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva

Also Published As

Publication number Publication date
AU616555B2 (en) 1991-10-31
EP0356945B1 (de) 1993-11-24
PT91584A (pt) 1990-03-08
DK428089D0 (da) 1989-08-30
JPH02108633A (ja) 1990-04-20
DE58906241D1 (de) 1994-01-05
AU4090589A (en) 1990-03-08
PT91584B (pt) 1995-05-31
DE3829523A1 (de) 1990-03-01
EP0356945A2 (de) 1990-03-07
EP0356945A3 (de) 1991-07-31
KR900002791A (ko) 1990-03-23
ATE97576T1 (de) 1993-12-15
ES2061842T3 (es) 1994-12-16

Similar Documents

Publication Publication Date Title
DK463989A (da) Farmaceutisk virksom kombination
DE3686410D1 (de) Stabilisierte zusammensetzungen von menschlichen aktivatoren des gewebeplasminogens.
FI872917A0 (fi) Farmaceutiska baerare, vilka frigoer aktivaemnet reglerbart.
ATE50493T1 (de) Ibuprofen enthaltendes arzneimittel.
BR1100622A (pt) Processo anti-cd20 quimérico imunologicamenteativo, e, composição farmacêutica
DK163173C (da) Fremgangsmaade til fremstilling af et lyofiliseret farmaceutisk praeparat af vaevs-plasminogenaktivator (t-pa)
DK428089D0 (da) Anvendelse af plasminogen-aktivator-inhibitor (pai-2) til immunsuppression
DK427989A (da) Anvendelse af transgluataminaser som immunosuppresiva
SE8803085L (sv) Dosform foer avgivande av diltiazem
DK0638068T3 (da) Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
DK305490D0 (da) Vaevsplasminogenaktivator-analoger med forbedret aktivitet
DK427886A (da) Farmaceutiske praeparater indeholdende inhibitorer af angiotensin-omdannende enzyn til behandling af hoejt blodtryk
DK0589741T3 (da) Anvendelse af en direkte thrombininhibitor til fremstilling af et lægemiddel med thrombolytisk aktivitet
JO1120B1 (en) N- (1-night-2-pyrrolidinyl-methyl) 2-methoxy-4-amino-5-methylsulfamoyil benzamide, method of preparation and use as a drug
IT1262900B (it) Dispositivo per iniezione di soluzioni farmaceutiche contenute in cartuccia
DE59008693D1 (de) Gewebs-Plasminogen-Aktivator-Derivat.
ES2146607T3 (es) Mezcla proteolitica que contiene escarasa y metodo de aislar la misma.
AU612562B2 (en) A composition comprising a plasmin inhibitor and a plasminogen activator for the treatment of thrombosis
UA7778A1 (uk) 13-[(2s) 2-аміно-4-карбоксибутаноіл]-1, 4, 7, 10 тетраокса-13-азаціклопентадекан гідрохлорід, який має антиамнестичну і антигіпоксичну дію
GR3003285T3 (en) Antiperspirants with alpha-2-adrenergic amine activity
RO101301B1 (ro) Dispozitiv limitator diferential

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment